申请人:Pfizer Inc.
公开号:US07615651B2
公开(公告)日:2009-11-10
Compounds of Formula (I) that act as antagonists at the mu, kappa and/or delta opioid receptors and therefore useful in the treatment of diseases, conditions and/or disorders that benefit from such antagonism in animals are described herein.
where R, R1, R2a, R2b, R3, R4, V, R6, R7, R8, R9, W and X are described herein.
本文描述了化学式(I)的化合物,其在mu、kappa和/或delta阿片受体上起拮抗作用,因此在动物中治疗受益于此种拮抗作用的疾病、情况和/或障碍方面有用。
其中R、R1、R2a、R2b、R3、R4、V、R6、R7、R8、R9、W和X在本文中有所描述。